Citations

Clear

4801 citation(s) found for "Yu, Jennifer".

Treatment of Brain Metastases: The Synergy of Radiotherapy and Immune Checkpoint Inhibitors
Matsui, Jennifer K. , Perlow, Haley K. , Raj, Rohit K., Nalin, Ansel P. , Lehrer, Eric J. , Kotecha, Rupesh , McClelland, Shearwood , Kendra, Kari , Williams, Nicole , Thomas, Evan , Beyer, Sasha , Blakaj, Dukagjin , Ahluwalia, Manmeet S. , Raval, Raju R. , Palmer, Joshua D. , Kendra, Kari , Palmer, Joshua D , Ahluwalia, Manmeet S , Perlow, Haley K , Trifiletti, Daniel M. , Owen, Dwight H , Presley, Carolyn J.

Mayo Clinic

Biomedicines | September 7, 2022 | Volume: 10 | Issue: 9 | Pages: 2211

10.3390/biomedicines10092211 | PMID 36140312 Get It

Brain metastases are a devastating sequela of common primary cancers (e.g., lung, breast, and skin) and have limited effective therapeutic options. Previously, systemic chemotherapy failed to demonstrate significant benefit in patients with brain metastases, but in recent decades, targeted therapies and more recently immune checkpoint inhibitors (ICIs) have yielded promising results in preclinical and clinical studies. Furthermore, there is significant interest in harnessing the immunomodulatory effects of radiotherapy (RT) to synergize with ICIs. Herein, we discuss studies evaluating the impact of RT dose and fractionation on the immune response, early studies supporting the synergistic interaction between RT and ICIs, and ongoing clinical trials assessing the benefit of combination therapy in patients with brain metastases.
Beyond the AJR: Why Was N-Acetylcysteine Considered an Effective Pretreatment for Contrast-Induced Acute Kidney Injury for So Long?
McDonald, Jennifer S.

Mayo Clinic

American Journal of Roentgenology | September 7, 2022 | Volume: 220 | Issue: 5 | Pages: 761-761

10.2214/ajr.22.28431 | PMID 36069487 Get It

International Consensus Statement on Obstructive Sleep Apnea
Chang, Jolie L. , Goldberg, Andrew N. , Alzoubaidi, Mohammed , Ashbrook, Liza , Auckley, Dennis , Ayappa, Indu , Bakhtiar, H., Bartley, Bethany L. , Billings, Martha E. , Boon, Maurits , Bosschieter, Pien F. N. , Braverman, Itzhak , Brodie, Kara D. , Caesar, Ray, Cahali, Michel Burihan, Cai, Yi , Cao, Michelle , Capasso, Robson , Caples, Sean M., Chang, Corissa P. , Chang, Katherine W. , Chaudhary, Nilika, Cheong, Crystal , Chowdhuri, Susmita , Cistulli, Peter A. , Claman, David M., Collen, Jacob , Coughlin, Kevin , Creamer, Jennifer , Davis, Eric M. , Dupuy-McCauley, Kara , Durr, Megan L. , Dutt, Mohan, Ali, Mazen El, Elkassabany, Nabil , Epstein, Lawrence J., Fiala, Justin A. , Freedman, Neil, Gill, Kirat, Gillespie, M. Boyd , Golisch, Lea, Gooneratne, Nalaka S., Gottlieb, Daniel J. , Green, Katherine K., Gurubhagavatula, Indira , Hayward, Nathan, Hoffmann, Oliver M. G., Holfinger, Steven , Hsia, Jennifer, Huoh, Kevin C. , Inala, Sanjana , Jobanputra, Aesha M. , Johnson, Andrew P. , Junna, Mithri R. , Kado, Jenna T. , Kaffenberger, Thomas M. , Khan, Meena , Kirsch, Douglas B. , Kominsky, Alan, Kryger, Meir H. , Kushida, Clete A. , Kuzniar, Thomas J., Lim, Diane C , Liu, Stanley Yung‐Chuan , MacKay, Stuart G. , Maurer, Joachim T. , May, Anna M. , Mitchell, Ron B. , Mullins, Anna , Nada, Eman , Naik, Sreelatha , Nokes, Brandon , Olson, Michael D. , Pang, Edward B. , Pang, Kenny P. , Perck, Eli Van de , Piccirillo, Jay F. , Pien, Grace W. , Plawecki, Andrea , Quigg, Mark , Ravesloot, Madeline J. L. , Redline, Susan , Rotenberg, Brian , Ryden, Armand, Sarmiento, Kathleen , Sbeih, Firas , Schell, Amy E., Schotland, Helena , Schwab, Richard J. , Seo, Jiyeon , Shah, Neomi , Shelgikar, Anita V., Shochat, Isaac , Soose, Ryan J. , Steele, Toby O. , Stephens, Erika M. , Stepnowsky, Carl , Thaler, Erica R. , Thapa, Sritika, Vries, Nico de, Weaver, Edward M. , Weir, Ian, Wolfe, Lisa F. , Woodson, B. Tucker , Won, Christine , Xu, Josie , Yalamanchi, Pratyusha , Yaremchuk, Kathleen , Yeghiazarians, Yerem, Yu, Jason L. , Zeidler, Michelle , Rosen, Ilene M. , Alt, Jeremiah A , Mohammed, Alzoubaidi , Ashbrook, Liza , Auckley, Dennis , Ayappa, Indu , Bartley, Bethany L , Braverman, Itzhak , Cahali, Michel B , Cai, Yi , Cheong, Crystal S J , Chowdhuri, Susmita , Cistulli, Peter A , Creamer, Jennifer , Dupuy-McCauley, Kara L , Durr, Megan L , Elkassabany, Nabil M , Fiala, Justin A , Gottlieb, Daniel J , Gulati, Arushi , Holfinger, Steven J , Huntley, Colin , Huyett, Phillip , Inala, Sanjana , Ishman, Stacey L , Jobanputra, Aesha M , Kado, Jenna T , Kezirian, Eric J , Kirsch, Douglas B , Kushida, Clete A , Lam, Derek J , Lettieri, Christopher J , Lin, Hsin-Ching , Magalang, Ulysses J , Malhotra, Atul , Mansukhani, Meghna P , Maurer, Joachim T , May, Anna M , Mitchell, Ron B , Mullins, Anna E , Nada, Eman M , Naik, Sreelatha , Nokes, Brandon T , Pack, Allan I , Pien, Grace W , Piper, Amanda J , Ravesloot, Madeline J L , Redline, Susan , Rotenberg, Brian W , Sarmiento, Kathleen F , Schmickl, Christopher N , Shelgikar, Anita Valanju , Shochat, Isaac , Soose, Ryan J , Steele, Toby O , Stephens, Erika , Strohl, Kingman P , Suurna, Maria V , Vanderveken, Olivier M , Yu, Jason L , Rosen, Ilene M , Alt, Jeremiah A. , Barrera, Jose Enrique , Cabrera‐Muffly, Cristina , Chahine, Lana M. , Hoff, Paul T. , Ishman, Stacey L. , Jella, Tarun K. , Kapur, Vishesh K. , Kezirian, Eric J. , Krystal, Andrew D. , Lam, Derek J. , Malhotra, Atul , Mansukhani, Meghna P. , Mokhlesi, Babak , Pack, Allan I , Patil, Susheel P. , Sutherland, Kate

Mayo Clinic

International Forum of Allergy & Rhinology | September 7, 2022 | Volume: 13 | Issue: 7 | Pages: 1061-1482

10.1002/alr.23079 | PMID 36068685 Get It

ABSTRACT Background Evaluation and interpretation of the literature on obstructive sleep apnea (OSA) allows for consolidation and determination of the key factors important for clinical management of the adult OSA patient. Toward this goal, an international collaborative of multidisciplinary experts in sleep apnea evaluation and treatment have produced the International Consensus statement on Obstructive Sleep Apnea (ICS:OSA). Methods Using previously defined methodology, focal topics in OSA were assigned as literature review (LR), evidence‐based review (EBR), or evidence‐based review with recommendations (EBR‐R) formats. Each topic incorporated the available and relevant evidence which was summarized and graded on study quality. Each topic and section underwent iterative review and the ICS:OSA was created and reviewed by all authors for consensus. Results The ICS:OSA addresses OSA syndrome definitions, pathophysiology, epidemiology, risk factors for disease, screening methods, diagnostic testing types, multiple treatment modalities, and effects of OSA treatment on multiple OSA‐associated comorbidities. Specific focus on outcomes with positive airway pressure (PAP) and surgical treatments were evaluated. Conclusion This review of the literature consolidates the available knowledge and identifies the limitations of the current evidence on OSA. This effort aims to create a resource for OSA evidence‐based practice and identify future research needs. Knowledge gaps and research opportunities include improving the metrics of OSA disease, determining the optimal OSA screening paradigms, developing strategies for PAP adherence and longitudinal care, enhancing selection of PAP alternatives and surgery, understanding health risk outcomes, and translating evidence into individualized approaches to therapy.
Abstract A13: Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome
Guièze, Romain , Johnson, Connor, Tausch, Eugen , Lemvigh, Camilla K. , Messer, Conor, Levovitz, Chaya , Broséus, Julien , Li, Shuqiang , Lin, Ziao , Knisbacher, Binyamin A. , Schneider, Christof , Rassenti, Laura Z., Cymbalista, Florence, Livak, Kenneth J. , Brown, Jennifer R. , Paridi, Laxmi, Getz, Gaddy, Wu, Catherine J. , Parry, Erin M. , Leshchiner, Ignaty , Parikh, Sameer A. , Utro, Filippo , Rhrissorrakrai, Kahn , Davids, Matthew S. , Kipps, Thomas J. , Jain, Nitin , Wierda, William G. , Kay, Neil E. , Danysh, Brian P. , Stewart, Chip , Neuberg, Donna , Stilgenbauer, Stephan

Mayo Clinic

Blood Cancer Discovery | September 6, 2022 | Volume: 3 | Issue: 5_Supplement | Pages: A13-A13

10.1158/2643-3249.lymphoma22-a13 Get It

Abstract Richter syndrome (RS), an aggressive lymphoma that develops in patients with chronic lymphocytic leukemia (CLL), is a striking example of histologic transformation. While recent therapeutic advances have transformed the treatment landscape of CLL and lymphoma, RS remains associated with dismal overall survival. Despite an advanced genomic and molecular characterization of CLL over the past decade, the current understanding of the genetic factors driving evolution of CLL to RS is limited. To decipher the genetics underlying this transformation, we have performed an integrative analysis of exome, genome and transcriptome data generated from matched RS and CLL samples from a discovery cohort of 53 patients with newly diagnosed RS of DLBCL histology. Through computational deconvolution of CLL and RS clones, we constructed phylogenetic relationships and traced evolution of CLL to RS, confirming both clonal related (87%) and unrelated cases (13%). In addition to identifying recognized RS-risk genetic lesions, we discovered novel RS-specific alterations, including 5 putative somatic driver genes (IRF2BP2, SRSF1, B2M, DNMT3A and EZH2), frequent copy number alterations beyond del(9p21)(CDKN2A/B), (including amp(7q21.2) (CDK6), amp(9p24) (PDL1/L2), and amp(1q23)(MCL1)), and recurrent whole genome duplication and chromothripsis. Integration of exome and genome sequencing data led to the identification of distinct molecular subtypes of RS with prognostic importance. To confirm these molecular subtypes, a validation cohort of 47 RS cases has been assembled with paired exome and transcriptome data. To further investigate the stepwise clonal evolution of CLL to RS, we performed single-cell RNA-sequencing on biopsy samples obtained at diagnosis from 5 individuals with clonally related transformation. Using a novel tool, CNVSingle, we inferred allele specific single-cell copy number alterations that enabled identification of the single-cell clusters representing distinct CLL and RS genetic subclones as well as intermediate, or transitional, evolutionary states. RS cells displayed gene expression enriched in pathways of MYC targets and cell cycle, in line with similar analysis on bulk transcriptomes. Finally, by ultra-low pass (ULP)-WGS sequencing of plasma samples from RS patients, we demonstrate detection of RS tumor DNA in plasma months prior to initial clinical diagnosis (n=3 of 6) or post-allogeneic stem cell transplant relapse (n=2 of 2). cfDNA is thus a promising tool for early detection of emerging RS and RS relapse as well as for non-invasive detection surrounding diagnosis. Altogether, our study defines RS-specific alterations and provides a molecular definition of RS, identifies distinct genetic subtypes of RS with prognostic significance, traces the evolutionary path to RS and suggests future strategies for improved detection. Citation Format: Erin M Parry, Ignaty Leshchiner, Romain Guieze, Connor Johnson, Eugen Tausch, Sameer A Parikh, Camilla K Lemvigh, Conor Messer, Filippo Utro, Chaya Levovitz, Kahn Rhrissorrakrai, Matthew S Davids, Julien Broseus, Shuqiang Li, Ziao Lin, Binyamin A Knisbacher, Christof Schneider, Laura Z Rassenti, Thomas J Kipps, Nitin Jain, William Wierda, Florence Cymbalista, Neil E Kay, Kenneth J Livak, Brian P Danysh, Chip Stewart, Donna Neuberg, Jennifer R Brown, Laxmi Paridi, Stephan Stilgenbauer, Gaddy Getz, Catherine Wu. Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndrome [abstract]. In: Proceedings of the Third AACR International Meeting: Advances in Malignant Lymphoma: Maximizing the Basic-Translational Interface for Clinical Application; 2022 Jun 23-26; Boston, MA. Philadelphia (PA): AACR; Blood Cancer Discov 2022;3(5_Suppl):Abstract nr A13.
Standards of Care for the Health of Transgender and Gender Diverse People, Version 8
Coleman, Eli , Bouman, Walter Pierre , Brown, George R. , Vries, A. de , Deutsch, Madeline B. , Ettner, Randi, Fraser, Lin, Goodman, Michael , Green, J., Hancock, Adrienne B. , Johnson, Thomas W. , Karasic, Dan H., Knudson, Gail, Leibowitz, Scott , Meyer‐Bahlburg, Heino F. L. , Monstrey, S., Motmans, Joz , Nahata, Leena , Reisner, Sari L. , Richards, Christina , Schechter, Loren S. , Tangpricha, Vin , Tishelman, Amy C. , Trotsenburg, M.A.A. van , Winter, Sam , Ducheny, Kelly , Adams, Noah S. , Adrián, T. M., Allen, Luke R. , Azul, David , Bagga, Harjit, Başar, Koray , Bathory, D. S., Belinky, Javier, Berg, Dianne , Berli, Jens U. , Bluebond‐Langner, Rachel , Bouman, Mark‐Bram , Bowers, Marci, Brassard, P., Byrne, Jack, Cargill, C. J., Carswell, Jeremi M. , Chang, Sand C. , Chelvakumar, Gayathri, Corneil, Trevor , Dalke, Katharine B. , Cuypere, Griet De , Vries, Elma De , Devor, Aaron , D’Marco, A., Edmiston, E. Kale , Edwards-Leeper, Laura, Ehrbar, Randall D., Ehrensaft, Diane , Eisfeld, Justus, Elaut, Els , Erickson‐Schroth, Laura, Feldman, Jamie , Garcia, Maurice M. , Gijs, Luk , Green, S. E., Hall, B. P., Hardy, Teresa L. D. , Jacobs, Laura A., Klink, Daniel, Kuper, Laura E. , Kvach, Elizabeth, Malouf, Matthew A., Massey, Ren, Mazur, Tom, McLachlan, Chris tine, Mosser, Scott W., Neira, Paula M. , Nygren, Ulrika , Oates, Jennifer , Pagkalos, Georgios, Patton, J., Rachlin, Katherine, Reed, T., Rider, G. Nic , Ristori, Jiska , Robbins-Cherry, Sally, Roberts, Stephanie , Sabir, K., Seal, Leighton , Sehoole, T. J. , Spencer, K., Amand, Colt St. , Strang, John F. , Taylor, G. B., Vala, L. N., Vencill, Jennifer A. , Wesp, Linda , Rider, G. Nic , Tangpricha, Vin , Roberts, Stephanie A , Radix, Asa E. , Nieder, Timo Ole , Capitán, Luis Pérez , Heijer, Martin den , Dhejne, Cecilia , Fisher, Alessandra D. , Irwig, Michael S. , Jacobs, L. A., Janssen, Aron C. , Johnson, Katherine , Kreukels, Baudewijntje P.C. , McLachlan, Christine , Morrison, Shane D. , Obedin‐Maliver, Juno , Phanuphak, Nittaya , Reed, T., Rodriguez-Wallberg, Kenny A , Rosenthal, Stephen M. , Safer, Joshua D. , Scheim, Ayden I. , Steensma, Thomas D. , Tilleman, Kelly , T’Sjoen, Guy , Mello, Norah M. van , Veale, Jaimie F. , Vincent, Ben , West, Michael A. , Arcelus, Jon

Mayo Clinic

International Journal of Transgender Health | September 6, 2022 | Volume: 23 | Issue: sup1 | Pages: S1-S259

10.1080/26895269.2022.2100644 | PMID 36238954 Get It

Gender and Geographic Origin as Determinants of Manuscript Publication Outcomes: JBMR® Bibliometric Analysis from 2017 to 2019
Rivadeneira, Fernando , Loder, Randall T. , McGuire, Anthony C., Chitwood, Joseph, Duffy, Katie , Civitelli, Roberto , Kacena, Melissa A. , Westendorf, Jennifer J. , Westendorf, Jennifer J

Mayo Clinic

Journal of Bone and Mineral Research | September 5, 2022 | Volume: 37 | Issue: 12 | Pages: 2420-2434

10.1002/jbmr.4696 | PMID 36063372 Get It

Abstract The Journal of Bone and Mineral Research (JBMR®), the flagship journal of the American Society for Bone and Mineral Research (ASBMR), enjoys a premiere position in its field and has a global reach. The journal uses a single-blind peer-review process whereby three editors are typically involved in assessing each submission for publication, in addition to external reviewers. Although emphasizing fairness, rigor, and transparency, this process is not immune to the influence of unconscious biases. The gender and geographic diversity of JBMR® authors, editors, and reviewers has increased over the last three decades, but whether such diversity has affected peer-review outcomes is unknown. We analyzed manuscript acceptance rates based on the gender and geographic origin of authors, reviewers, and Associate Editors. The analysis included 1662 original research articles submitted to JBMR® from September 2017 through December 2019. Gender was assigned using probabilities from an online tool and manually validated through internet searches. Predictor variables of manuscript outcome were determined with multivariate logistic regression analysis. The acceptance rate was highest when the first and last authors were of different genders, and lowest when both authors were men. Reviewer gender did not influence the outcome regardless of the genders of the first and last authors. Associate Editors from all geographical regions tended to select reviewers from their same region. The acceptance rate was highest when the Associate Editor was from Europe. Manuscripts with authors from North America and Australia/New Zealand had greater overall odds of acceptance than those from Europe and Asia. Manuscripts reviewed only by Editorial Board (EB) members had a lower acceptance rate than those refereed by non-EB reviewers or a mix of EB and non-EB reviewers. Overall, the geographical origin of authors, reviewers, and editors, as well as reviewers' EB membership may influence manuscript decisions. Yet, the JBMR® peer-review process remains largely free from gender bias. © 2022 American Society for Bone and Mineral Research (ASBMR).
Quality of Life and Cognitive Function Evaluations and Interventions for Patients with Brain Metastases in the Radiation Oncology Clinic
Matsui, Jennifer K. , Perlow, Haley K. , Baiyee, Cyril, Ritter, Alex R., Mishra, Mark V. , Bovi, Joseph , Gondi, Vinai , Brown, Paul D. , Leeper, Heather , Dawson, Erica , Palmer, Joshua D. , Bovi, Joseph A , Leeper, Heather E , Dawson, Erica , Palmer, Joshua D , Mishra, Mark V , Perlow, Haley K , Loughan, Ashlee R.

Mayo Clinic

Cancers | September 1, 2022 | Volume: 14 | Issue: 17 | Pages: 4301

10.3390/cancers14174301 | PMID 36077835 Get It

Brain metastases (BMs) account for a disproportionately high percentage of cancer morbidity and mortality. Historically, studies have focused on improving survival outcomes, and recent radiation oncology clinical trials have incorporated HRQOL and cognitive assessments. We are now equipped with a battery of assessments in the radiation oncology clinic, but there is a lack of consensus regarding how to incorporate them in modern clinical practice. Herein, we present validated assessments for BM patients, current recommendations for future clinical studies, and treatment advances that have improved HRQOL and cognitive outcomes for BM patients.
Ovarian Signet-ring Stromal Tumor
Tchrakian, Naïri , Oliva, Esther , Rivera-Polo, Barbara, Nucci, Marisa R. , Sah, Shatrughan Prasad , Schoolmeester, J. Kenneth , Griend, Rachael van der , Young, Robert H. , McCluggage, W. Glenn , Chong, Anne‐Sophie , Bennett, Jennifer A. , Foulkes, William D. , Clarke, Blaise

Mayo Clinic

American Journal of Surgical Pathology | August 30, 2022 | Volume: 46 | Issue: 12 | Pages: 1599-1610

10.1097/pas.0000000000001954 | PMID 36040033 Get It

Signet-ring stromal tumor (SRST) is a rare ovarian stromal neoplasm characterized by a population of bland signet-ring cells, devoid of mucin or lipid, in a generally cellular fibromatous stroma. Previous reports have described heterogenous immunohistochemical and molecular genetic findings, including occasional nuclear β-catenin expression and/or CTNNB1 mutations. We report 10 ovarian stromal neoplasms originally diagnosed as SRST. All but 1 tumor underwent detailed immunohistochemical analysis (including β-catenin) and 5 of 10 had CTNNB1 mutation analysis performed. All tumors contained a population of morphologically bland signet-ring cells that ranged from 15% to 95% of the neoplasm, characterized by a single large empty intracytoplasmic vacuole, mostly with nuclear indentation. Six of the 10 tumors contained cellular fibroma-like areas, comprising from 10% to 85% of the neoplasm. Three of the 10 tumors were reclassified as microcystic stromal tumor with signet-ring cells on the basis of the microcyst formation and hyalinized stroma, beta-catenin and cyclin D1 nuclear expression and/or CTNNB1 mutation, CD10 staining and largely absent expression of inhibin and calretinin. In the remaining 7 tumors, the diagnosis of SRST remained, constituting the largest series of SRST reported in the literature to date. The results of our study suggest that a subset of tumors diagnosed as ovarian SRST, especially those which show β-catenin nuclear positivity and/or CTNNB1 mutation, likely represent microcystic stromal tumor with variant morphology. We also suggest that at least a subset of SRSTs without evidence of Wnt/β-catenin pathway abnormalities may be related to ovarian fibromas. We discuss the differential diagnosis of ovarian neoplasms containing signet-ring cells.
Gadolinium-based contrast agents for imaging of the central nervous system: A multicenter European prospective study
Behzadi, Ashkan Heshmatzadeh , Heshmatzadeh Behzadi, Ashkan , McDonald, Jennifer , McDonald, Jennifer S.

Mayo Clinic

Medicine | August 30, 2022 | Volume: 101 | Issue: 34 | Pages: e30163

10.1097/md.0000000000030163 | PMID 36042629 Get It

Contrast-enhanced MR (CE-MR) imaging is required to improve lesion detection and characterization and to increase diagnostic confidence. This study aims to evaluate the safety, effectiveness, and usage patterns of recently introduced Clariscan TM (gadoterate meglumine) and other macrocyclic gadolinium-based contrast agents (GBCAs) used for magnetic resonance imaging (MRI) of the central nervous system (CNS). Data was obtained from a European multicenter, prospective, observational postmarketing study that included pediatric and adult patients undergoing contrast-enhanced MRI with a GBCA used in routine clinical practice. Safety data was collected by spontaneous patient adverse event (AE) reporting. Effectiveness was assessed via changes in radiological diagnosis, diagnostic confidence, and image quality. 766 patients with CNS-related indications were included from 8 centers across 5 European countries between December 2018 and November 2019. Clariscan (gadoterate meglumine) was used in 66% (503) of exams, Dotarem ® (gadoterate meglumine) in 20% (160), Gadovist ® (gadobutrol) in 13% (97), and ProHance ® (gadoteridol) in 1%. GBCA use increased the diagnostic confidence in 95% (724/766) of patients and a change in radiological diagnosis in 65% (501/766) of patients. The Clariscan-specific data revealed an increase in diagnostic confidence in 94% (472/503) of patients and resulted in a change in radiological diagnosis in 58% (293/503) of patients. Image quality was considered excellent or good in 95% of patients across all GBCAs and in 94% of patients who received Clariscan. No AEs were reported in this cohort including Clariscan. This data demonstrates the excellent safety and efficacy profile of Clariscan and other GBCAs used in MRI examination of the CNS.
Family Use of Remote Infant Viewing in the Neonatal Intensive Care Unit: Impact of the COVID-19 Pandemic and Patient Room Type
Patel, Rahul , Kreofsky, Beth L. , Morgan, Katie M., Weaver, Amy L. , Fang, Jennifer L. , Patel, Rahul K , Brumbaugh, Jane E.

Mayo Clinic

Telemedicine and e-Health | August 29, 2022 | Volume: 29 | Issue: 4 | Pages: 531-539

10.1089/tmj.2022.0195 | PMID 36036802 Get It